Physician profile
Patrick Dolan
NPI 1144648767
$6,286.97
in general payments reported to CMS, 2019-2025
11 companies · $4,192 in 2025
The $4,192 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $876 · 2023: $407 · 2024: $811 · 2025: $4,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $910.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,519.01 | 2022-2025 | Da Vinci Surgical System |
| Shockwave Medical, INC | $140.31 | 2022 | |
| Medtronic, INC. | $123.50 | 2022 | |
| Currax Pharmaceuticals LLC | $117.74 | 2024-2025 | Contrave |
| Novo Nordisk INC | $113.83 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $86.08 | 2024-2025 | Zepbound, Mounjaro |
| Becton, Dickinson and Company | $75.46 | 2023 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $38.21 | 2024 | Gattex |
| Teleflex LLC | $37.84 | 2024 | Weck, Titan Sgs |
| Intra-Sana Laboratories | $17.64 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Davol INC. | $17.35 | 2023 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.